BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25675681)

  • 1. Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy.
    Laohawiriyakamol S; Sunpaweravong S; Leelamanit V; Pruegsanusak K; Sinkijcharoenchai W
    J Med Assoc Thai; 2014 Nov; 97(11):1164-70. PubMed ID: 25675681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
    Bugter O; van de Ven SEM; Hardillo JA; Bruno MJ; Koch AD; Baatenburg de Jong RJ
    Head Neck; 2019 Apr; 41(4):1122-1130. PubMed ID: 30593712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
    Morita FH; Bernardo WM; Ide E; Rocha RS; Aquino JC; Minata MK; Yamazaki K; Marques SB; Sakai P; de Moura EG
    BMC Cancer; 2017 Jan; 17(1):54. PubMed ID: 28086818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of upper digestive endoscopy using lugol dye solution for the diagnosis of superficial esophageal cancer and dysplasia in patients with head and neck neoplasms].
    Tincani AJ; Brandalise N; Andreollo NA; Lopes LR; Montes CG; Altemani A; Martins AS
    Arq Gastroenterol; 2000; 37(2):107-13. PubMed ID: 11144012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.
    Boller D; Spieler P; Schoenegg R; Neuweiler J; Kradolfer D; Studer R; Grossenbacher R; Zuercher U; Meyenberger C; Borovicka J
    Surg Endosc; 2009 Dec; 23(12):2748-54. PubMed ID: 19444514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fujinon intelligent color enhancement for the diagnosis of early esophageal squamous cell carcinoma and precancerous lesion.
    Li YX; Shen L; Yu HG; Luo HS; Yu JP
    Turk J Gastroenterol; 2014 Aug; 25(4):365-9. PubMed ID: 25254516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study.
    Gong EJ; Kim DH; Ahn JY; Choi KS; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY
    Dis Esophagus; 2016 Oct; 29(7):752-759. PubMed ID: 26471351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer.
    Hori K; Okada H; Kawahara Y; Takenaka R; Shimizu S; Ohno Y; Onoda T; Sirakawa Y; Naomoto Y; Yamamoto K
    Am J Gastroenterol; 2011 May; 106(5):858-66. PubMed ID: 21468010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.
    Dubuc J; Legoux J-; Winnock M; Seyrig J-; Barbier J-; Barrioz T; Laugier R; Boulay G; Grasset D; Sautereau D; Grigoresco D; Butel J; Scoazec J-; Ponchon T;
    Endoscopy; 2006 Jul; 38(7):690-5. PubMed ID: 16874909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of lugol chromoendoscopy in the oesophagus in patients with head and neck cancer.
    Carvalho R; Areia M; Brito D; Saraiva S; Alves S; Cadime AT
    Rev Esp Enferm Dig; 2013 Feb; 105(2):79-83. PubMed ID: 23659506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of probe-based confocal laser endomicroscopy in Lugol-unstained esophageal superficial lesions of patients with head and neck cancer.
    Safatle-Ribeiro AV; Baba ER; Faraj SF; Rios JT; de Lima MS; Martins BC; Geiger SN; Pennacchi C; Gusman C; Kawaguti FS; Uemura RS; de Melo ES; Ribeiro U; Maluf-Filho F
    Gastrointest Endosc; 2017 Jun; 85(6):1195-1207. PubMed ID: 27697445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
    Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
    Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lugol chromoendoscopy as a diagnostic tool in so-called endoscopy-negative GERD.
    Yoshikawa I; Yamasaki M; Yamasaki T; Kume K; Otsuki M
    Gastrointest Endosc; 2005 Nov; 62(5):698-703; quiz 752, 754. PubMed ID: 16246682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial.
    Chaber-Ciopinska A; Kiprian D; Wieszczy P; Bielasik A; Bugajski M; Januszewicz W; Jarzabski A; Niemiec M; Mroz A; Kawecki A; Regula J; Kaminski MF
    Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of magnifying narrow band imaging endoscopy for esophageal cancer screening.
    Yamasaki Y; Takenaka R; Hori K; Takemoto K; Kawano S; Kawahara Y; Okada H; Fujiki S; Yamamoto K
    World J Gastroenterol; 2015 Mar; 21(9):2793-9. PubMed ID: 25759551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
    Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
    J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LUGOL'S IODINE CHROMOENDOSCOPY VERSUS NARROW BAND IMAGE ENHANCED ENDOSCOPY FOR THE DETECTION OF ESOPHAGEAL CANCER IN PATIENTS WITH STENOSIS SECONDARY TO CAUSTIC/CORROSIVE AGENT INGESTION.
    Pennachi CMPS; Moura DTH; Amorim RBP; Guedes HG; Kumbhari V; Moura EGH
    Arq Gastroenterol; 2017; 54(3):250-254. PubMed ID: 28492712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% lugol dye solution in patients with head and neck cancer.
    Tincani AJ; Brandalise N; Altemani A; Scanavini RC; Valério JB; Lage HT; Molina G; Martins AS
    Head Neck; 2000 Mar; 22(2):170-4. PubMed ID: 10679905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.
    Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB
    Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.